Skip to main content
Sign In
 

Welcome to Child Neurology

The Department of Pediatrics Section of Child Neurology is nationally recognized for providing outstanding consultation, clinical care, and surgery for children and adolescents with neurological disorders. U.S. News & World Report ranked Child Neurology as one of the top 15 programs in the nation.

Services offered include comprehensive evaluation and treatment of neurological disorders, parent and patient education, comprehensive neurological consultation services, and inpatient and outpatient treatment.

Child Neurology's faculty members - which include physicians, neuropsychologists, researchers, nurse practitioners & physician assistants - are active in teaching, scholarship, advocacy, and translational and clinical research in the neurosciences that will lead to improved treatment options for patients with neurological disorders.

As the largest medical center in the western region providing such broad expertise, Child Neurology at Children's Hospital Colorado is the referral center for children and adolescents with neurological disorders for much of the western U.S.

Please explore our Web site for more information.

Clinical ServicesCLINICAL SERVICES
Child Neurology at Children's Colorado treats more than 17,000 patients per year  MORE »



EducationEDUCATION
We offer a variety of educational programs including a 3-year, ACGME-accredited Residency Program  MORE »



ResearchRESEARCH
Clinical and translational neuroscience investigations focus on improving understanding and treatment  MORE »


HIGHLIGHTS & NEWS

  • Jennifer Armstrong, MD, MPH, FAHA, was selected as one of 10 neurologists, and the only child neurologist, to participate in the 2018 Diversity Leadership Program of the American Academy of Neurology​. The program is a yearlong leadership training and mentoring experience for neurologists from underrepresented minorities. Participants also serve on a task force to create policies and activities related to diversification strategy of the AAN.

  • Bloomberg: "A Drug From Cannabis Moves Closer to Approval in U.S."​ - U.S. drug regulators are getting closer to approving Epidiolex, the first ever pharmacy-grade medicine derived from a marijuana plant to help treat two rare forms of childhood epilepsy. Charuta Joshi, MD, was quoted.

  • Amy Brooks-Kayal, MD, has been appointed as 2018 Neurology Director of the American Board of Psychiatry and Neurology​.

  • “There’s some hope for this horrible disorder, (hope) to improve the lives and quality of life for our children and young adults with SMA....That’s pretty darned exciting," said Julie Parsons, MD, in a January 2018 Coloradoan news story​.

​​​​​​